Celtic Catalysts was among the four Irish biotech companies, all members of IBEC’s Irish BioIndustry Association (IBIA), who took part in the international “Rising Stars Showcase” competition along with 8 other companies from Scotland and Israel. Each of the participants pitched their companies and development strategies to a panel of experts and an invited audience before Celtic Catalysts was announced the overall winner after a confident and polished pitch by Kevin Dalton, Sales Director.
Dr Brian Kelly and Professor Declan Gilheany co-founded Celtic Catalysts in 2000 as a spin-out from UCD’s School of Chemistry and Chemical Biology. Celtic Catalysts currently employs a staff of 17 and is headquartered in NovaUCD, the Innovation and Technology Transfer Centre at UCD.
Celtic Catalysts’ focus is on the area of chiral synthesis and it has developed a comprehensive portfolio of intellectual property and carved out a uniquely strong niche for itself in the specialised area of P-chiral technology. This technology can be used in the production of a range of drugs which are particularly prevalent in anti-viral and anti-cancer therapeutic areas.
Commenting on the win, Dr Brian Kelly, CEO said, “Celtic Catalysts is delighted to have won this international award. It is a wonderful endorsement of the tremendous hard work of our team over many years to develop and build our IP portfolio and our strategy of translating that portfolio into a dynamic and growing business of international reach.”
The IBIA is the leading representative body for the biotechnology industry in Ireland. Celtic Catalysts and the three other Irish companies who took part in this competition; BiancaMed, which is also based in NovaUCD, EnBio and Luxcel Biosciences are all working on pioneering technologies which will ultimately improve the health and wellbeing of people all around the globe.
Eleanor Garvey, chair of IBIA and Site Leader in Pfizer Ireland, Dún Laoghaire, said, “It is extremely encouraging to see Celtic Catalysts an Irish biotech company win an internationally competition of this calibre.” She added, “Ireland continues to punch well above its weight at a global level and it is important that indigenous Irish companies have the necessary supports to attain their commercial potential.”
Miceal Whelan | alfa
CRTD receives 1.56 Mill. Euro BMBF-funding for retinal disease research
24.05.2017 | DFG-Forschungszentrum für Regenerative Therapien TU Dresden
BMBF funds translational project to improve radiotherapy
10.05.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
26.05.2017 | Life Sciences
26.05.2017 | Life Sciences
26.05.2017 | Physics and Astronomy